Gwak H - Search Results

1

Prognostic Impact of Multiple Synchronous T1 Breast Cancer.

Gwak H, Jung SH, Suh YJ, Nam SJ, Han JH, Oh SJ, Park EH, Kim SH. Gwak H, et al. Cancers (Basel). 2024 Nov 30;16(23):4019. doi: 10.3390/cancers16234019. Cancers (Basel). 2024. PMID: 39682205 Free PMC article.

2

A Comparison of the Prognostic Effects of Fine Needle Aspiration and Core Needle Biopsy in Patients with Breast Cancer: A Nationwide Multicenter Prospective Registry.

Gwak H, Woo SS, Oh SJ, Kim JY, Shin HC, Youn HJ, Chun JW, Lee D, Kim SH. Gwak H, et al. Cancers (Basel). 2023 Sep 19;15(18):4638. doi: 10.3390/cancers15184638. Cancers (Basel). 2023. PMID: 37760607 Free PMC article.

3

The effect of adjuvant chemotherapy on survival in Korean patients with node negative T1c, triple negative breast cancer.

Lim ST, Park CH, Kim SY, Nam SJ, Kang EY, Moon BI, Lee HJ, Jeon YW, Gwak H, Suh YJ. Lim ST, et al. Among authors: gwak h. PLoS One. 2018 May 16;13(5):e0197523. doi: 10.1371/journal.pone.0197523. eCollection 2018. PLoS One. 2018. PMID: 29768496 Free PMC article.

4

Relative Survival Benefit by Hormonal Receptor Status of Adding Trastuzumab to Neoadjuvant Chemotherapy in Breast Cancer Patients.

Schneider J, Lee HJ, Nam SJ, Lee SJ, Jung JH, Jung SH, Lim ST, Jeon YW, Gwak H. Schneider J, et al. Among authors: gwak h. J Breast Cancer. 2020 Jun;23(3):259-267. doi: 10.4048/jbc.2020.23.e34. J Breast Cancer. 2020. PMID: 32595988 Free PMC article.

5

Clinical Implications of Serum 25-Hydroxyvitamin D Status after 5-Year Adjuvant Endocrine Therapy for Late Recurrence of Hormone Receptor-positive Breast Cancer.

Lim ST, Jeon YW, Gwak H, Suh YJ. Lim ST, et al. Among authors: gwak h. J Breast Cancer. 2020 Oct;23(5):498-508. doi: 10.4048/jbc.2020.23.e58. J Breast Cancer. 2020. PMID: 33154825 Free PMC article.

6

Clinical Impact of Primary Prophylactic Pegfilgrastim in Breast Cancer Patients Receiving Adjuvant Docetaxel-Doxorubicin-Cyclophosphamide Chemotherapy.

Jeon YW, Lim ST, Gwak H, Park SY, Suh YJ. Jeon YW, et al. Among authors: gwak h. J Breast Cancer. 2020 Oct;23(5):521-532. doi: 10.4048/jbc.2020.23.e52. J Breast Cancer. 2020. PMID: 33154827 Free PMC article.

7

Synergistic anticancer effects of ruxolitinib and calcitriol in estrogen receptor‑positive, human epidermal growth factor receptor 2‑positive breast cancer cells.

Lim ST, Jeon YW, Gwak H, Kim SY, Suh YJ. Lim ST, et al. Among authors: gwak h. Mol Med Rep. 2018 Apr;17(4):5581-5588. doi: 10.3892/mmr.2018.8580. Epub 2018 Feb 8. Mol Med Rep. 2018. PMID: 29436642 Free PMC article.

8

Incidence, Risk Factors, and Clinical Implications of Delayed Hypoparathyroidism on Postoperative Day two Following Total Thyroidectomy for Papillary Thyroid Carcinoma.

Lim ST, Jeon YW, Gwak H, Suh YJ. Lim ST, et al. Among authors: gwak h. Endocr Pract. 2020 Jul;26(7):768-776. doi: 10.4158/EP-2019-0544. Epub 2020 Nov 24. Endocr Pract. 2020. PMID: 33471646

9

Clinical utilization of long-acting granulocyte colony-stimulating factor (pegfilgrastim) prophylaxis in breast cancer patients with adjuvant docetaxel-cyclophosphamide chemotherapy.

Jeon YW, Lim ST, Gwak H, Park SY, Shin J, Han HS, Suh YJ. Jeon YW, et al. Among authors: gwak h. Ann Surg Treat Res. 2021 Feb;100(2):59-66. doi: 10.4174/astr.2021.100.2.59. Epub 2021 Feb 1. Ann Surg Treat Res. 2021. PMID: 33585350 Free PMC article.

10

Nomogram for the Prediction of Biochemical Incomplete Response in Papillary Thyroid Cancer Patients.

Lim ST, Jeon YW, Gwak H, Bae JS, Suh YJ. Lim ST, et al. Among authors: gwak h. Cancer Manag Res. 2021 Jul 13;13:5641-5650. doi: 10.2147/CMAR.S320993. eCollection 2021. Cancer Manag Res. 2021. PMID: 34285584 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

395 results

Search Page

Filters